Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.39 is 92% above its 5-year average of -17.91, near the high end of its 5-year range (-44.90–-0.25).
58.86% below its 12-month average of -0.88.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.34.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:28:09.643Z. Historical observations retain their original dates. Historical series through 2006-05-12.
EARNINGS PER SHARE (EPS)
-1.39
EARNINGS PER SHARE (EPS) AVG TTM
-0.88
EARNINGS PER SHARE (EPS) AVG 3Y
-6.06
EARNINGS PER SHARE (EPS) AVG 5Y
-17.91
EARNINGS PER SHARE (EPS) AVG 10Y
-32.86
EARNINGS PER SHARE (EPS) AVG 15Y
-33.56
EARNINGS PER SHARE (EPS) AVG 20Y
-34.37
CURRENT VS TTM AVG
-58.86%
CURRENT VS 3Y AVG
+77.07%
CURRENT VS 5Y AVG
+92.24%
CURRENT VS 10Y AVG
+95.77%
CURRENT VS 15Y AVG
+95.86%
CURRENT VS 20Y AVG
+95.96%
Rockwell Medical, Inc.
Market Cap
$32.68M
Earnings Per Share (EPS)
-1.39
TTM Avg
-0.88
3Y Avg
-6.06
5Y Avg
-17.91
Market Cap
$32.92M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$33.17M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
Market Cap
$33.25M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$33.32M
Earnings Per Share (EPS)
-0.40
TTM Avg
-0.21
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$33.71M
Earnings Per Share (EPS)
-64.88
TTM Avg
-36.48
3Y Avg
-29.14
5Y Avg
-27.68
Market Cap
$31.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
Market Cap
$31.44M
Earnings Per Share (EPS)
0.37
TTM Avg
-0.28
3Y Avg
0.68
5Y Avg
0.80
Market Cap
$34.04M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | $32.68M | -1.39 | -0.88 | -6.06 | -17.91 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.92M | -2.56 | -5.45 | -15.27 | -9.79 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.17M | -7.30 | -11.70 | -7.29 | -5.93 |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | -0.52 | -0.68 | -0.92 | -0.73 |
| Accuray Incorporated (ARAY)vs › | $33.32M | -0.40 | -0.21 | -0.17 | -0.13 |
| Scilex Holding Company (SCLX)vs › | $33.71M | -64.88 | -36.48 | -29.14 | -27.68 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.58M | N/A | -0.24 | -0.01 | 0.39 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 0.37 | -0.28 | 0.68 | 0.80 |
| Elutia Inc (ELUT)vs › | $34.04M | 0.94 | -0.29 | -1.25 | -1.59 |
| SCYNEXIS, Inc. (SCYX)vs › | $30.97M | -1.84 | -2.44 | -1.37 | -9.44 |
Trailing EPS (TTM)
$-1.39
Forward EPS (Est.)
$-1.01
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.50 |
| 2024-12-31 | -0.25 |
| 2023-12-31 | -3.60 |
| 2022-12-31 | -18.90 |
| 2021-12-31 | -38.30 |
| 2020-12-31 | -44.90 |
| 2019-12-31 | -56.10 |
| 2018-12-31 | -66.90 |
| 2017-12-31 | -56.10 |
| 2016-12-31 | -43.00 |
| 2015-12-31 | -31.90 |
| 2014-12-31 | -57.20 |
| 2013-12-31 | -163.20 |
| 2012-12-31 | -291.50 |
| 2011-12-31 | -133.10 |
| 2010-12-31 | -17.60 |
| 2009-12-31 | -40.70 |
| 2008-12-31 | -62.50 |
| 2007-12-31 | -35.20 |
| 2006-12-31 | -45.10 |
| 2005-12-31 | 1.10 |
| 2004-12-31 | 2.20 |
| 2003-12-31 | 0.04 |
| 2002-12-31 | -14.00 |
| 2001-12-31 | -30.10 |
| 2000-12-31 | -23.00 |
| 1999-12-31 | -24.20 |
| 1998-12-31 | -43.10 |
| 1997-12-31 | -42.30 |
